Sareum Raises GBP681,484 to Fund Clinical Research Program
26 Junho 2019 - 04:30AM
Dow Jones News
By Carlo Martuscelli
Sareum Holdings PLC (SAR.LN) has raised 681,484 pounds
($867,297) in a share issue to help fund its clinical-development
pipeline.
The AIM-listed company said Wednesday that it issued 170.4
million shares at 0.4 pence each--a 27% discount to its closing
price on Monday, the day before offer was announced.
Sareum said it will use the proceeds of the capital raise to
fund its TYK2/JAK1 inhibitor programs.
Together with the completed placing announced on Tuesday, Sareum
raised GBP1.2 million pounds.
Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com
(END) Dow Jones Newswires
June 26, 2019 03:15 ET (07:15 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Sareum (LSE:SAR)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Sareum (LSE:SAR)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024